Open AccessPotential for cardiac protection with dipeptidyl peptidase‐4 inhibitors: The stromal cell‐derived factor‐1α hypothesis (二肽基肽酶‐4抑制剂潜在的心脏保护作用：基质细胞衍生因子‐1α假说)
Author(s) -
Gilbert Richard E.
Publication year - 2013
Publication title -
journal of diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.949
H-Index - 43
eISSN - 1753-0407
pISSN - 1753-0393
DOI - 10.1111/1753-0407.12053
Subject(s) - medicine , sitagliptin , dipeptidyl peptidase 4 , diabetes mellitus , saxagliptin , myocardial infarction , odds ratio , heart failure , meta analysis , adverse effect , incretin , disease , clinical trial , alogliptin , risk factor , incidence (geometry) , type 2 diabetes , endocrinology , physics , optics